• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常血糖性糖尿病酮症酸中毒与钠-葡萄糖协同转运蛋白2抑制剂:病理生理学、危险因素及诱发因素的重点综述

Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers.

作者信息

Somagutta Manoj R, Agadi Kuchalambal, Hange Namrata, Jain Molly S, Batti Erkan, Emuze Bernard O, Amos-Arowoshegbe Elizabeth O, Popescu Sorin, Hanan Saad, Kumar Varadha Retna, Pormento Kezia

机构信息

Department of Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Department of Medicine, Avalon University School of Medicine, Willemstad, CUW.

出版信息

Cureus. 2021 Mar 3;13(3):e13665. doi: 10.7759/cureus.13665.

DOI:10.7759/cureus.13665
PMID:33824816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8012260/
Abstract

Diabetic ketoacidosis (DKA) is an acute and significant life-threatening complication of diabetes. The association of sodium-glucose cotransporter-2 inhibitors (SGLT2i) with euglycemic diabetic ketoacidosis (EDKA) has been well reported. This literature review was conducted to understand the mechanism of EDKA and identify the potential risk factors and precipitants for patients taking SGLT2i. After reviewing the published literature between 2010 and 2020, 32 articles are included in the final review. The underlying mechanism is mainly enhanced lipolysis and ketone body reabsorption. SGLT2i also stimulates pancreatic alpha cells and inhibits beta cells, causing an imbalance in glucagon/insulin levels, further contributing to lipolysis and ketogenesis. Most patients were diagnosed with blood glucose less than 200 mg/dL, blood pH <7.3, increased anion gap, increased blood, or urine ketones. Perioperative fasting, pancreatic etiology, low carbohydrate or ketogenic diet, obesity, and malignancy are identified precipitants in this review. As normoglycemia can conceal the underlying acidosis, physicians should be cognizant of the EDKA diagnosis and initiate prompt treatment. Patient education on risk factors and triggers is recommended to avoid future events.

摘要

糖尿病酮症酸中毒(DKA)是糖尿病一种严重的急性危及生命的并发症。钠-葡萄糖协同转运蛋白2抑制剂(SGLT2i)与正常血糖性糖尿病酮症酸中毒(EDKA)之间的关联已有充分报道。进行本次文献综述旨在了解EDKA的机制,并确定服用SGLT2i患者的潜在风险因素和诱发因素。在回顾了2010年至2020年间发表的文献后,最终纳入综述的文章有32篇。其潜在机制主要是脂肪分解增强和酮体重吸收增加。SGLT2i还刺激胰腺α细胞并抑制β细胞,导致胰高血糖素/胰岛素水平失衡,进一步促进脂肪分解和酮生成。大多数患者诊断时血糖低于200mg/dL,血pH<7.3,阴离子间隙增加,血或尿酮体增加。围手术期禁食、胰腺病因、低碳水化合物或生酮饮食、肥胖和恶性肿瘤是本综述中确定的诱发因素。由于正常血糖可能掩盖潜在的酸中毒,医生应认识到EDKA的诊断并及时开始治疗。建议对患者进行危险因素和诱发因素的教育,以避免未来发生此类情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccb/8012260/dd4dbfac4732/cureus-0013-00000013665-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccb/8012260/884a7d0b4396/cureus-0013-00000013665-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccb/8012260/c248fdc20ccc/cureus-0013-00000013665-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccb/8012260/dd4dbfac4732/cureus-0013-00000013665-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccb/8012260/884a7d0b4396/cureus-0013-00000013665-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccb/8012260/c248fdc20ccc/cureus-0013-00000013665-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eccb/8012260/dd4dbfac4732/cureus-0013-00000013665-i03.jpg

相似文献

1
Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers.正常血糖性糖尿病酮症酸中毒与钠-葡萄糖协同转运蛋白2抑制剂:病理生理学、危险因素及诱发因素的重点综述
Cureus. 2021 Mar 3;13(3):e13665. doi: 10.7759/cureus.13665.
2
Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports.钠-葡萄糖协同转运蛋白2抑制剂诱发的正常血糖性糖尿病酮症酸中毒:病例报告的Meta综述
World J Diabetes. 2023 Aug 15;14(8):1314-1322. doi: 10.4239/wjd.v14.i8.1314.
3
Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Bariatric Surgery: A Case and Literature Review.减重手术后钠-葡萄糖协同转运蛋白2抑制剂相关的正常血糖性糖尿病酮症酸中毒:一例病例及文献综述
Cureus. 2021 Aug 11;13(8):e17093. doi: 10.7759/cureus.17093. eCollection 2021 Aug.
4
Dietary Changes Leading to Euglycemic Diabetic Ketoacidosis in Sodium-Glucose Cotransporter-2 Inhibitor Users: A Challenge for Primary Care Physicians?钠-葡萄糖协同转运蛋白2抑制剂使用者中导致血糖正常的糖尿病酮症酸中毒的饮食变化:对初级保健医生的一项挑战?
Korean J Fam Med. 2022 Nov;43(6):361-366. doi: 10.4082/kjfm.22.0003. Epub 2022 Nov 20.
5
A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂诱发正常血糖性糖尿病酮症酸中毒治疗前景的文献综述
Cureus. 2022 Sep 27;14(9):e29652. doi: 10.7759/cureus.29652. eCollection 2022 Sep.
6
Severe Prolonged SGLT2i-induced Euglycemic Diabetic Ketoacidosis Refractory to Standard Therapy and Dialysis: Case Report and Literature Review.严重且持续时间长的SGLT2抑制剂所致血糖正常性糖尿病酮症酸中毒对标准治疗和透析难治:病例报告及文献综述
Oman Med J. 2022 May 31;37(3):e373. doi: 10.5001/omj.2022.17. eCollection 2022 May.
7
Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence.钠-葡萄糖共转运蛋白 2 抑制剂致住院患者围手术期糖尿病酮症酸中毒:病例系列研究的经验教训及降低发生率的策略
Endocr Pract. 2022 Sep;28(9):884-888. doi: 10.1016/j.eprac.2022.06.006. Epub 2022 Jun 23.
8
Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.正常血糖性糖尿病酮症酸中毒:病因、评估与管理
Am J Emerg Med. 2021 Jun;44:157-160. doi: 10.1016/j.ajem.2021.02.015. Epub 2021 Feb 16.
9
An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists.一例伴有波折的隐匿性正常血糖性糖尿病酮症酸中毒病例。
Cureus. 2022 Apr 10;14(4):e24016. doi: 10.7759/cureus.24016. eCollection 2022 Apr.
10
A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.1例SGLT2抑制剂所致正常血糖性糖尿病酮症酸中毒病例
Cureus. 2022 Oct 9;14(10):e30106. doi: 10.7759/cureus.30106. eCollection 2022 Oct.

引用本文的文献

1
Perioperative prevention of euglycaemic diabetic ketoacidosis in people living with type 2 diabetes established on sodium-glucose transport-2 inhibitors - a cross-site multi-cycle audit.对使用钠-葡萄糖协同转运蛋白2抑制剂治疗的2型糖尿病患者围手术期正常血糖性糖尿病酮症酸中毒的预防——一项跨机构多周期审计
Clin Med (Lond). 2025 Aug 12;25(5):100502. doi: 10.1016/j.clinme.2025.100502.
2
Euglycaemic diabetic ketoacidosis and its risk factors in patients undergoing coronary artery bypass grafting surgery: a single-centre nested case-control study in China.冠状动脉旁路移植术患者的正常血糖性糖尿病酮症酸中毒及其危险因素:中国一项单中心巢式病例对照研究
BMJ Open. 2025 Aug 12;15(8):e098758. doi: 10.1136/bmjopen-2025-098758.
3

本文引用的文献

1
SUCCESSFUL REIMPLEMENTATION OF A VERY LOW CARBOHYDRATE KETOGENIC DIET AFTER SGLT2 INHIBITOR ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS.SGLT2抑制剂相关正常血糖性糖尿病酮症酸中毒后极低碳水化合物生酮饮食的成功重新实施
AACE Clin Case Rep. 2020 Aug 6;6(6):e330-e333. doi: 10.4158/ACCR-2020-0314. eCollection 2020 Nov-Dec.
2
Euglycemic Diabetic Ketoacidosis Precipitated by a Keto Diet: Importance of Dietary History in Diagnosis.生酮饮食诱发的正常血糖性糖尿病酮症酸中毒:饮食史在诊断中的重要性
Cureus. 2020 Sep 2;12(9):e10199. doi: 10.7759/cureus.10199.
3
SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report.
SGLT2 Inhibitors: From Structure-Effect Relationship to Pharmacological Response.
钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂:从构效关系到药理反应
Int J Mol Sci. 2025 Jul 19;26(14):6937. doi: 10.3390/ijms26146937.
4
Sodium Glucose Cotransporter Inhibition in Acute Heart Failure: An In-Depth Review.急性心力衰竭中钠葡萄糖协同转运蛋白抑制作用:深入综述
CJC Open. 2024 Dec 27;7(4):380-389. doi: 10.1016/j.cjco.2024.12.008. eCollection 2025 Apr.
5
Intraoperative Diagnosis of Sodium-Glucose Transporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis.钠-葡萄糖协同转运蛋白2抑制剂相关正常血糖性糖尿病酮症酸中毒的术中诊断
Cureus. 2024 Oct 20;16(10):e71931. doi: 10.7759/cureus.71931. eCollection 2024 Oct.
6
The lower incidence of cervical cancer in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors utilization.2型糖尿病患者使用钠-葡萄糖协同转运蛋白2抑制剂后宫颈癌发病率降低。
J Cancer. 2024 Oct 14;15(19):6196-6203. doi: 10.7150/jca.101165. eCollection 2024.
7
Euglycemic diabetic ketoacidosis in the setting of acute intracerebral hemorrhage.急性脑出血背景下的正常血糖性糖尿病酮症酸中毒
Surg Neurol Int. 2024 Aug 16;15:284. doi: 10.25259/SNI_295_2024. eCollection 2024.
8
Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis.钠-葡萄糖协同转运蛋白2抑制剂相关正常血糖性酮症酸中毒高危人群择期手术延续的新方法
Diabetes Spectr. 2024 Spring;37(2):165-169. doi: 10.2337/ds23-0040. Epub 2024 Mar 15.
9
Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Associated Diabetic Ketoacidosis in Oncology Patients: A Case Series and Literature Review.钠-葡萄糖协同转运蛋白2抑制剂(SGLT2i)相关的肿瘤患者糖尿病酮症酸中毒:病例系列及文献综述
Cureus. 2024 Feb 7;16(2):e53816. doi: 10.7759/cureus.53816. eCollection 2024 Feb.
10
Euglycemic Diabetic Ketoacidosis Presenting as Hypoglycemia in a Patient With Type 2 Diabetes and Von Gierke's Disease.在一名2型糖尿病合并冯·吉尔克病患者中,正常血糖性糖尿病酮症酸中毒表现为低血糖症。
Cureus. 2024 Jan 11;16(1):e52104. doi: 10.7759/cureus.52104. eCollection 2024 Jan.
钠-葡萄糖协同转运蛋白2抑制剂所致正常血糖性糖尿病酮症酸中毒:一例报告
Kidney Med. 2020 Feb 22;2(2):218-221. doi: 10.1016/j.xkme.2019.12.006. eCollection 2020 Mar-Apr.
4
Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.恩格列净治疗的 2 型糖尿病患者发生多因素病因的严重血糖正常性糖尿病酮症酸中毒:病例报告及文献复习。
BMC Nephrol. 2020 Jul 15;21(1):276. doi: 10.1186/s12882-020-01930-6.
5
Euglycemic Diabetic Ketoacidosis in Concurrent Very Low-carbohydrate Diet and Sodium-glucose Transporter-2 Inhibitor Use: A Case Report.同时采用极低碳水化合物饮食和使用钠-葡萄糖协同转运蛋白2抑制剂时出现的正常血糖性糖尿病酮症酸中毒:一例报告
Clin Pract Cases Emerg Med. 2020 Apr 23;4(2):185-188. doi: 10.5811/cpcem.2020.2.45904. eCollection 2020 May.
6
Latent Autoimmune Diabetes in Adults: A Review of Clinically Relevant Issues.成人隐匿性自身免疫性糖尿病:临床相关问题综述。
Adv Exp Med Biol. 2021;1307:29-41. doi: 10.1007/5584_2020_533.
7
Euglycemic Diabetic Ketoacidosis in a Young Pregnant Woman Precipitated by Urinary Tract Infection.一名年轻孕妇因尿路感染引发正常血糖性糖尿病酮症酸中毒
Cureus. 2020 Mar 19;12(3):e7331. doi: 10.7759/cureus.7331.
8
Sodium-Glucose Cotransporter 2 Inhibitor-Associated Prolonged Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: A Case Report and Literature Review.2型糖尿病中钠-葡萄糖协同转运蛋白2抑制剂相关的持续性血糖正常的糖尿病酮症酸中毒:一例报告及文献综述
Clin Diabetes. 2020 Jan;38(1):112-116. doi: 10.2337/cd19-0035.
9
10. Cardiovascular Disease and Risk Management: .10. 心血管疾病与风险管理: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S111-S134. doi: 10.2337/dc20-S010.
10
Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and "Sweet Pee Encephalopathy" in Perioperative Hospital Management.与SGLT-2抑制剂相关的术后血糖正常性糖尿病酮症酸中毒和脑病:1例病例报告及围手术期医院管理中糖尿病治疗与“甜尿脑病”的讨论
Neurohospitalist. 2020 Jan;10(1):51-54. doi: 10.1177/1941874419835035. Epub 2019 Mar 7.